Terconazole

Generic Name
Terconazole
Brand Names
Terazol 3
Drug Type
Small Molecule
Chemical Formula
C26H31Cl2N5O3
CAS Number
67915-31-5
Unique Ingredient Identifier
0KJ2VE664U
Background

Terconazole is an anti-fungal drug that is mainly used to treat vaginal yeast infections (or vaginal candidiasis). It is classified as a triazole ketal derivative. Terconazole was initially approved by the FDA in 1987. This drug is available in cream and suppository forms and both have demonstrated high levels of safety, efficacy, and tolerability in clinica...

Indication

For the treatment of candidiasis (a yeast-like fungal infection) of the vulva and vagina.

Associated Conditions
Vulvovaginal Candidiasis
Associated Therapies
-

Ketoconazole Gel Versus Terconazole Cream for Vaginal Candidiasis

First Posted Date
2018-03-22
Last Posted Date
2018-03-22
Lead Sponsor
Assiut University
Target Recruit Count
69
Registration Number
NCT03473418

Multi-Center Study of New Medications to Treat Vaginal Infections

Phase 3
Completed
Conditions
Interventions
First Posted Date
2014-12-04
Last Posted Date
2020-07-27
Lead Sponsor
Curatek Pharmaceuticals, LLC
Target Recruit Count
212
Registration Number
NCT02308046
Locations
🇺🇸

KO Clinical Research, LLC, Fort Lauderdale, Florida, United States

🇺🇸

Women's Clinic of Lincoln, Lincoln, Nebraska, United States

🇺🇸

Women's Clinical Research Center, Seattle, Washington, United States

and more 38 locations

Multi-Center Study of New Medications to Treat Vaginal Infections

First Posted Date
2014-12-04
Last Posted Date
2020-08-04
Lead Sponsor
Curatek Pharmaceuticals, LLC
Target Recruit Count
475
Registration Number
NCT02308007
Locations
🇺🇸

Georgia Regents University, Augusta, Georgia, United States

🇺🇸

Mount Vernon CLinical Research, Sandy Springs, Georgia, United States

🇺🇸

Women's Health Practice, Champaign, Illinois, United States

and more 48 locations
© Copyright 2024. All Rights Reserved by MedPath